TMFGBudwell

George Budwell

TMFGBudwell’s Activity

Today

NL

Article

gbudwell published an article 4:44 AM

5 Things Bristol-Myers Squibb Co.'s Management Wants You to Know

Bristol-Myers Squibb reported third-quarter earnings last week. Here are five things management wants investors to know.

Yesterday

NL

Article

gbudwell published an article 8:53 PM

5 Things GlaxoSmithKline plc Stock's Management Wants You to Know

GlaxoSmithKline held its third-quarter conference call last week. Here's what the company's management wants you to know.

Mon Oct 27

NL

Article

gbudwell published an article 10:17 AM

Why Sarepta Therapeutics Inc Stock Is Crashing Today

Shares of clinical-stage biotech Sarepta Therapeutics fell by nearly 40% this morning. Here's why.

Fri Oct 24

NL

Article

gbudwell published an article 8:36 AM

Bristol-Myers Squibb Co's Third-Quarter Earnings Beat the Street

Bristol-Myers Squibb reported third-quarter earnings this morning. Here's what you need to know.

Wed Oct 22

NL

Article

gbudwell published an article 8:36 AM

Key Takeaways From GlaxoSmithKline's Third-Quarter Earnings

British Pharma GlaxoSmithKline reported third-quarter earnings this morning. Here's what you need to know.

NL

Article

gbudwell published an article 3:51 AM

3 Beaten Down Biotech Stocks to Buy Now

The share prices of Dynavax Technologies, CellDex Therapeutics, and Clovis Oncology have all plunged this year. Here is why I think these beaten down biotechs are now compelling buys.

Mon Oct 20

NL

Article

gbudwell published an article 9:44 AM

Will Marijuana-Based Pharmaceuticals Make Drugs More Affordable?

Marijuana-based pharmaceuticals are becoming a reality. Will these "natural" products come with the added benefit of lower price tags compared to their man-made counterparts?

NL

Article

gbudwell published an article 8:13 AM

Is Johnson & Johnson's Worst Nightmare Becoming Reality?

Johnson & Johnson has become a growth story on the back of strong pharmaceutical sales over the past two quarters. This trend looks like it is about to change with the approval of a rival's game-changing drug.

Fri Oct 17

NL

Article

gbudwell published an article 5:51 AM

Can This 1 Breast Cancer Drug Turn Pfizer Inc. Into a Growth Stock?

The world's largest pharmaceutical company, Pfizer, looks lost amid its staggering patent cliff problem. Could this experimental breast cancer drug put Pfizer back on track for growth?

Thu Oct 16

NL

Article

gbudwell published an article 7:04 AM

3 Stocks I'll Buy if the Market Crashes

The market could be in the midst of a major downturn. Here are three stocks to consider buying if the market does crash.

Wed Oct 15

NL

Article

gbudwell published an article 9:29 AM

Why Shire plc Is Today's Worst Biotech Stock

Shire's stock is falling hard this morning. Here's why.

Tue Oct 14

NL

Article

gbudwell published an article 4:20 AM

Why You Shouldn't Buy Ebola Stocks

The share prices of companies leading the fight against Ebola have been soaring lately. Is this investor enthusiasm justified?

Fri Oct 10

NL

Article

gbudwell published an article 6:59 AM

Is Now the Perfect Time to Buy Marijuana Stocks?

Legal marijuana is the fastest-growing industry in America right now. Is it time to invest?

Thu Oct 9

NL

Article

gbudwell published an article 11:06 AM

Why Gentiva Health Services, Inc. Stock Is Soaring Today

Kindred Healthcare has finally convinced Gentiva Health Services to get on board with a buyout. Here is what you need to know.

NL

Article

gbudwell published an article 10:18 AM

Why Auxilium Pharmaceuticals Inc. Stock Is Soaring Today

Endo International ups its offer for Auxilium Pharmaceuticals. Is it enough this time around?

Wed Oct 8

NL

Article

gbudwell published an article 7:14 AM

Can Dividend Stock GlaxoSmithKline plc Bounce Back?

British pharma GlaxoSmithKline is being accused of corruption in yet another country, the United Arab Emirates. Given all the problems facing the company these days, can Glaxo turn things around?

NL

Article

gbudwell published an article 5:23 AM

Actavis plc and Valeant Pharmaceuticals Inc. Battle for Allergan Inc.: Who Wins?

Valeant Pharmaceuticals upped its bid offer for Botox maker Allergan by $15 a share yesterday. Actavis reportedly responded with an even richer offer. Will activist investor Bill Ackman get his way or will six months of work go down the drain?

Sun Oct 5

NL

Article

gbudwell published an article 4:33 AM

Why Is Sanofi Betting on MannKind Corporation's Afrezza?

Sanofi's global dominance over the lucrative diabetes market is facing a serious challenge with the patent expiration of Lantus, the most commonly prescribed insulin in the world. Can MannKind's inhaled insulin product help Sanofi retain its edge?

Fri Oct 3

NL

Article

gbudwell published an article 8:12 AM

Why Is George Soros Buying Celgene Corporation?

George Soros' fund took out a huge position in Celgene Corporation in the second-quarter. Should you follow his lead?

NL

Article

gbudwell published an article 7:04 AM

Is Sarepta Therapeutics Inc. Stock a Short Sell?

Clinical stage biopharma Sarepta Therapeutics has attracted a large and growing short interest. Is the stock now a good short sell?

Show More Activity ...

CAPS Stats & Trivia

CAPS Player Rating < 20
Player Rank 0 out of 75058
Score 0.00
Score Change Today 0
Accuracy 0.00%
Active Picks 0
Total Picks 5
Best Pick RXII (+9.56)
Worst Pick IMUC (-28.72)
Average Score per Pick 0.00
Charms Earned 0
Highest Rated Favorite No Favorites Selected
Go to TMFGBudwell’s CAPS page

Boards Stats & Trivia

Board Posts 0
Recs Received 0
People who have rec'd these posts 0
Recs to Posts Ratio (last 30 days) N/A
Threads Started 0
Threads Started Percentage 0.00 %
Most Frequent Board N/A
Very First Post N/A
Percentage of Posts Rec'd 100.00 %
Show TMFGBudwell’s 10 Latest Posts